Efficacy Testing of H56 cDNA Tattoo Immunization against Tuberculosis in a Mouse Model

Efficacy Testing of H56 cDNA Tattoo Immunization against Tuberculosis in a Mouse Model

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a global threat. The only approved vaccine against TB, Mycobacterium bovis bacillus Calmette–Guérin (BCG), provides insufficient protection and, being a live vaccine, can cause disseminated disease in immunocompromised individual...

Full description

Bibliographic Details
Main Authors:	Anouk C. M. Platteel, Natalie E. Nieuwenhuizen, Teresa Domaszewska, Stefanie Schürer, Ulrike Zedler, Volker Brinkmann, Alice J. A. M. Sijts, Stefan H. E. Kaufmann
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-12-01
Series:	Frontiers in Immunology
Subjects:	tuberculosis vaccine vaccination DNA immunization Mycobacterium bovis bacillus Calmette–Guérin H56
Online Access:	http://journal.frontiersin.org/article/10.3389/fimmu.2017.01744/full

Similar Items

Next-Generation Vaccines Based on Bacille Calmette–Guérin
by: Natalie E. Nieuwenhuizen, et al.
Published: (2018-02-01)

A single strain of Mycobacterium bovis bacillus Calmette-Guérin (BCG) grown in two different media evokes distinct humoral immune responses in mice
by: V.L. Petricevich, et al.
Published: (2001-01-01)

A case of Mycobacterium bovis Bacillus Calmette-Guérin (BCG) strain meningitis and ventriculitis following BCG vaccination
by: Mihoko Furuichi, et al.
Published: (2020-11-01)

Integrating Non-human Primate, Human, and Mathematical Studies to Determine the Influence of BCG Timing on H56 Vaccine Outcomes
by: Louis R. Joslyn, et al.
Published: (2018-08-01)

Etymologia: M. bovis
Published: (2015-03-01)

Inadvertent intramuscular administration of high dose bacillus Calmette Guerin vaccine in a pre-term infant
by: Asima Banu, et al.
Published: (2013-01-01)

DISSEMINATED BACILLUS-CALMETTE-GUÉRIN INFECTIONS AND PRIMARY IMMUNODEFICIENCY DISORDERS IN SINGAPORE: A SINGLE CENTER 15-YEAR RETROSPECTIVE REVIEW
by: Rina Yue Ling Ong, et al.
Published: (2020-08-01)

Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology
by: Stefan H. E. Kaufmann, et al.
Published: (2020-02-01)

Development and Challenges in Animal Tuberculosis Vaccination
by: Ana Balseiro, et al.
Published: (2020-06-01)

Tuberculin reactivity in schoolchildren, Kassala State, Sudan
by: Fatima Abbas Khalid, et al.
Published: (2020-01-01)

Adverse reactions due to the bacillus Calmette-Guerin vaccine: Twenty Tunisian cases
by: Khadija Sellami, et al.
Published: (2018-01-01)

Complications following Bacille Calmette-Guérin Vaccination in Children under the Age of 18 Months: A Multi-center Study
by: Roxana Mansour Ghanaei, et al.
Published: (2019-01-01)

The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing
by: Natalie E. Nieuwenhuizen, et al.
Published: (2017-09-01)

Mycobacterium bovis Osteomyelitis of the Thoracic Spine Mimicking a Metastatic Lytic Lesion in a Patient Exposed to Intravesicular Bacille Calmette-Guérin Treatment
by: Jessica R. Newman, et al.
Published: (2014-07-01)

Evaluation of Children with Complication of BCG Vaccination in North of Iran
by: Mohammad Sadegh Rezai, et al.
Published: (2017-03-01)

Clinical Development of New TB Vaccines: Recent Advances and Next Steps
by: Mark Hatherill, et al.
Published: (2020-01-01)

Dual Bacillus Calmette–Guerin vaccination along the border communities of Angola and Namibia
by: Abubakar Sadiq Umar, et al.
Published: (2016-01-01)

Ten Years' Experience with the Discontinuation of the Bacillus Calmette–Guérin Vaccination in the Czech Republic
by: Karolína Dolezalová, et al.
Published: (2021-01-01)

Booster Dose of Bacille Calmette-Guérin Vaccine for Tuberculosis in Low and Middle-Income Countries: A Systematic Review
by: Oduwole OA, et al.
Published: (2021-09-01)

BCG lymphadenopathy detected in a BCG-vaccinated infant
by: A.S. Barouni, et al.
Published: (2004-05-01)

Search for Surrogate Marker(s) of Immunity Following Vaccination with Experimental Vaccine (Autoclaved Leishmania Major + Bacille Calmette-Guérin) in Human Volunteers
by: Mahmoodi, Majid
Published: (1998)

Lactobacilli Isolated From Wild Boar (Sus scrofa) Antagonize Mycobacterium bovis Bacille Calmette-Guerin (BCG) in a Species-Dependent Manner
by: Maria Bravo, et al.
Published: (2019-07-01)

Whole Blood Profiling of Bacillus Calmette–Guérin-Induced Trained Innate Immunity in Infants Identifies Epidermal Growth Factor, IL-6, Platelet-Derived Growth Factor-AB/BB, and Natural Killer Cell Activation
by: Steven G. Smith, et al.
Published: (2017-06-01)

TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development
by: Stefan H. E. Kaufmann, et al.
Published: (2017-10-01)

Characterizing the BCG Induced Macrophage and Neutrophil Mechanisms for Defense Against Mycobacterium tuberculosis
by: Thomas E. Bickett, et al.
Published: (2020-06-01)

Activation of M1 Macrophages in Response to Recombinant TB Vaccines With Enhanced Antimycobacterial Activity
by: Shiu-Ju Yang, et al.
Published: (2020-06-01)

Identification of Secreted O-Mannosylated Proteins From BCG and Characterization of Immunodominant Antigens BCG_0470 and BCG_0980
by: Guoying Deng, et al.
Published: (2020-03-01)

Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development
by: Samuel T. Pasco, et al.
Published: (2020-09-01)

Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model
by: Martin Rao, et al.
Published: (2017-03-01)

Searching For Calmette - Guérin Bacilli in Bone Marrow Specimens of Vaccinated Children: A Real-Time PCR
by: Ebrahim Sadeghi, et al.
Published: (2018-02-01)

Corrigendum: Activation of M1 Macrophages in Response to Recombinant TB Vaccines With Enhanced Antimycobacterial Activity
by: Shiu-Ju Yang, et al.
Published: (2021-03-01)

Association Between Antibiotic Treatment and the Efficacy of Intravesical BCG Therapy in Patients With High-Risk Non-Muscle Invasive Bladder Cancer
by: Sahyun Pak, et al.
Published: (2021-04-01)

Missense splice variant (g.20746A>G, p.Ile183Val) of interferon gamma receptor 1 (IFNGR1) coincidental with mycobacterial osteomyelitis - a screen of osteoarticular lesions
by: Agnieszka Bińczak-Kuleta, et al.
Published: (2016-08-01)

Over-expression of the mycobacterial trehalose-phosphate phosphatase OtsB2 results in a defect in macrophage phagocytosis associated with increased mycobacterial-macrophage adhesion
by: Hao Li, et al.
Published: (2016-11-01)

Vaccination-related Mycobacterium bovis BCG Infection
by: Anna Liberek, et al.
Published: (2006-05-01)

A case of infectious thoracic aortic aneurysm after intravesical Bacillus Calmette-Guérin instillation therapy for a superficial bladder cancer
by: Shigeki Koterazawa, et al.
Published: (2021-05-01)

Preclinical Progress of Subunit and Live Attenuated <i>Mycobacterium tuberculosis</i> Vaccines: A Review following the First in Human Efficacy Trial
by: Jacqueline Watt, et al.
Published: (2020-09-01)

Mycobacterium bovis infection of a femorofemoral bypass graft following intravesical Bacillus Calmette–Guérin (BCG) immunotherapy
by: Ryan K. Meyer, M.D., et al.
Published: (2020-05-01)

Increase in Lymphadenitis Cases after Shift in BCG Vaccine Strain
by: Giorgi Kuchukhidze, et al.
Published: (2015-09-01)

Case Report: BCG-Triggered Hemophagocytic Lymphohistiocytosis in an Infant With X-Linked Recessive Mendelian Susceptibility to Mycobacterial Disease Due to a Variant of Chronic Granulomatous Disease
by: Suleiman Al-Hammadi, et al.
Published: (2021-06-01)